Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Rinvoq
Rinvoq
AbbVie's Hopes of Replacing Humira Sales with Rinvoq Gains Momentum for Ulcerative Colitis
BioSpace
Wed, 12/9/20 - 11:21 pm
AbbVie
Rinvoq
ulcerative colitis
clinical trials
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
Endpoints
Wed, 12/9/20 - 10:39 am
AbbVie
Allergan
Humira
Rinvoq
4 AbbVie brands land on pharma's top TV spenders list for September
Fierce Pharma
Sat, 10/17/20 - 11:46 pm
television ads
DTC ads
AbbVie
Humira
Skyrizi
Rinvoq
Ubrelvy
AbbVie's Rinvoq Hits the Mark in Pivotal Phase III Dermatitis Trial
BioSpace
Wed, 07/22/20 - 11:37 pm
AbbVie
Rinvoq
atopic dermatitis
clinical trials
Big pharma heads towards important readouts
EP Vantage
Wed, 05/20/20 - 10:22 am
Ozempic
Novo Nordisk
etrolizumab
Roche
Ipatasertib
finerenone
Bayer
filgotinib
Gilead Sciences
Galapagos
Avalglucosidase alfa
Sanofi
Rinvoq
AbbVie
clinical trials
AbbVie Reports Successful Trial Results for Arthritis Drug
Motley Fool
Wed, 02/5/20 - 10:00 pm
AbbVie
Rinvoq
Upadacitinib
psoriasis
clinical trials
Pro-AbbVie bias may be driving rheumatologist confidence in newcomer Rinvoq: analyst
Fierce Pharma
Wed, 12/4/19 - 11:29 pm
AbbVie
Rinvoq
ICER says ‘marginal’ benefits for AbbVie’s new RA drug
Pharmaforum
Sat, 11/30/19 - 11:02 pm
ICER
AbbVie
Rinvoq
rheumatoid arthritis
biosimilars
AbbVie's new launches Skyrizi, Rinvoq aren't getting enough credit: analyst
Fierce Pharma
Sat, 11/23/19 - 04:15 pm
AbbVie
Skyrizi
Rinvoq
Allergan
drug launches
Is AbbVie's Imbruvica concerned about AZ's rising Calquence? We've got this covered, execs say
Fierce Pharma
Fri, 11/1/19 - 06:55 pm
AbbVie
Rinvoq
AstraZeneca
Calquence
Imbruvica
AbbVie eyes 2nd Rinvoq nod as it hits its marks in psoriatic arthritis
Fierce Pharma
Fri, 11/1/19 - 12:02 am
AbbVie
Rinvoq
FDA
psoriatic arthritis
AbbVie's blockbuster hopeful Rinvoq, J&J's Spravato eye EU rollouts, thanks to new backing
Fierce Pharma
Fri, 10/18/19 - 07:40 pm
AbbVie
Rinvoq
Europe
JNJ
Spravato
ICER says AbbVie’s Rinvoq for RA may be cost-effective but still questions the value of JAK class
Fierce Pharma
Fri, 10/11/19 - 11:53 am
ICER
AbbVie
Rinvoq
rheumatoid arthritis
JAK inhibitors
ICER pulls report blasting ‘marginal’ RA drugs, citing need to rethink its approach
Fierce Pharma
Wed, 10/2/19 - 11:53 am
ICER
JAK inhibitors
rheumatoid arthritis
AbbVie
Rinvoq
Pfizer
Xeljanz
Incyte
olumiant
AbbVie's Latest FDA Approval Is Its Most Important Immunology Win Since Humira
Motley Fool
Tue, 08/20/19 - 10:39 am
AbbVie
Rinvoq
Humira
immunology
AbbVie's Rinvoq label portends safety warnings for future JAKs—including Gilead's
Fierce Pharma
Tue, 08/20/19 - 09:45 am
JAK inhibitors
AbbVie
Rinvoq
FDA
Gilead Sciences
Price, safety will test blockbuster billing for AbbVie's new arthritis drug
Biopharma Dive
Sat, 08/17/19 - 12:14 am
AbbVie
rheumatoid arthritis
drug pricing
Rinvoq
Rinvoq approval bolsters AbbVie's autoimmune portfolio
BioCentury
Fri, 08/16/19 - 11:54 pm
AbbVie
FDA
Rinvoq
Upadacitinib
rheumatoid arthritis
Pages
« first
‹ previous
1
2
3